Consultant Cardiologist, Rigshospitalet,
Professor of Cardiology, University of Copenhagen, Denmark
Professor Søndergaard graduated in 1988 from University of Copenhagen and trained in cardiology at Rigshospitalet in Copenhagen, as well as Great Ormond Street Hospital for Sick Children and The Heart Hospital in London. He has a special interest in congenital and structural heart diseases, particular interventional procedures, and is Head of these programs at Rigshospitalet in Copenhagen. Prof Søndergaard lead the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012 and furthermore, the first-in-human implantation for the Gore Septal Occluder (2011), Inter Atrial Septal Device (Corvia) for HFpEF (2012), Hydra transcatheter aortic valve prosthesis (2013), and Lotus transcatheter aortic valve DepthGuard system (2016).
Professor of Cardiology at University of Copenhagen since 2015, his thesis ‘Quantitative assessment of aortic regurgitation and stenosis using magnetic resonance velocity mapping: Technical aspects and clinical evaluation’ was awarded with a DMSc degree from University of Copenhagen. He has published 189 peer reviewed articles, and 14 text book chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions. Lead principal investigator for several trials including the NOTION-1 and NOTION-2 randomised trials (investigating the role of transcatheter aortic valve replacement in younger, lower risk patients with aortic stenosis), NOTION-3 randomised trial (re-vascularization before TAVI), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).